Smart Money Alert

Ind-Swift Laboratories Limited

Newly DisclosedQuarterly

INDSWFTLABPharmaceuticalsMarket Cap₹3K Cr

Disclosed stake

2.96%

Holding

25.73 L shares

As of

Jun 2026

Since alert+46.9%₹237.60 → ₹349.05

Nifty 50+3.5%

Nova Global

Foreign Investor

The move

Nova Global entered Ind-Swift Laboratories with 25,72,991 shares, a 2.96% stake, valued at approximately ₹59.63 Cr.

About Ind-Swift Laboratories Limited

+ Follow Visit stock

A pharmaceutical manufacturer engaged in the production of bulk drugs and formulations, Ind-Swift Laboratories operates across India's medicinal compounds sector. Established in 1995, the company focuses on developing and supplying active pharmaceutical ingredients and finished dosage forms to both domestic and international markets. Its integrated operations span research, manufacturing, quality control, and distribution within the broader pharmaceutical value chain.

About Nova Global

+ Follow Visit investor

Nova Global Opportunities Fund PCC is a foreign portfolio investor that is an active anchor investor in Indian SME IPOs. It has backed offerings across sectors including electric equipment, power and energy, infrastructure, and logistics.

Get the next move the moment it happens.

Follow Nova Global and Ind-Swift Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Ind-Swift Laboratories Limited shareholders Nova Global's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Ind-Swift Laboratories Limited

Nova Global

Direction, size, price and stake change for this move, with what it means for the company.

15 Oct 2026. Sign in to see this move

Essix Biosciences LimitedIncreased

Essix Biosciences Limited and its persons acting in concert increased their stake in Ind-Swift Laboratories Limited from 43.06% to 47.18%, acquiring 70,00,000 fully convertible warrants on a preferential basis.